Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Little Green Pharma.
RELATED STOCKHEAD STORIES
Health & Biotech
What’s the best pot stock of 2021? And who’s targeting market domination in 2022?
Health & Biotech
ASX Health Stocks: The TGA rejects MMDA and magic mushrooms, deals blow to ASX psychedelic players
Health & Biotech
Weed Week: Uber Eats enters Canada’s cannabis market and Montu breaks crowdfunding records
Health & Biotech
BluView: Investors bullish on cannabis sector, and its pot stocks worth watching
Health & Biotech
Little Green Pharma ready to slide into international cannabis markets
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
Dr Boreham’s Crucible: 4 ASX stocks focused on a mind-altering $25 billion psilocybin market
Health & Biotech
The TGA could soon relax rules on psychedelics. Here are the ASX stocks that could benefit
Explainers
CBD Oil: The ultimate investor’s guide to a potential $64 billion global market
News
Weed Week: Cannabis-infused drinks market could reach US$2.8 billion by 2025
News
Pot stock Little Green Pharma flags plans to expand from cannabis to psychedelic medicines
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Pot Stocks: Roto-Gro jumps on Canniberia’s pre-approval for cannabis cultivation
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
Health & Biotech
ScoPo’s Powerplays: Buying opportunities in a volatile week
News